Guardant Health Inc (GH)

EBITDA Margin

-34.76%

TTM · Period ending:

GH logo

GH EBITDA Margin

Latest reported-34.76%
GH TTM EBITDA Margin (-141.50% → -34.76%)
High-resolution chart · PNG

GH ebitda margin history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Guardant Health Inc EBITDA Margin — Trailing twelve months (TTM)
Period endingEBITDA Margin
-34.7554%
-36.1946%
-38.0753%
-39.2332%
-44.441%
-47.8995%
-52.7892%
-67.4607%
-69.0347%
-68.6114%
-76.8342%
-71.9977%
-90.805%
-128.9647%
-136.7871%
-128.1373%
-122.9442%
-95.4869%
-96.2449%
-109.7822%
-106.1319%
-100.0943%
-78.4965%
-58.3323%
-39.875%
-26.7325%
-25.6247%
-33.127%
-48.6091%
-73.7744%
-85.2095%
-87.2094%
-110.0449%
-121.1756%
-141.4973%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.